Card image cap

Greg Walden's Public Statements on Issue: Drugs

Current Issue:

Drugs

Speech Type

All Debate Executive Order Floor Speech Hearing Interview Issue Position Letter News Article Op-Ed Other Pledge Press Conference Press Release Social Media Speech Statement

Date Range

Keyword Search
Reset Search
Page 1 of 8
Date Title
10/23/2020 Walden & Burgess on Anniversary of Landmark Legislation: Now is Not the Time to Let Our Foot Off the Gas
10/23/2020 Letter to Timothy Shea, Acting Administrator of the Drug Enforcement Administration - E&C GOP Leaders Question DEA on Opioid Supply Management
10/23/2020 #ForwardwithSUPPORT: Continuing Opioid Crisis Investigations
10/22/2020 #ForwardwithSUPPORT: E&C Republicans Continue Our Fight Against the Opioid Crisis
10/22/2020 #ForwardwithSUPPORT: National Drug Take Back Day and the 2nd Anniversary of the SUPPORT Act
10/14/2020 Letter to the Hon. Stephen Hahn, Commissioner of the Food and Drug Administration - E&C Republican Leaders Press FDA on OxyContin Labeling Change
09/11/2020 National Recovery Month
08/11/2020 Letter to the Hon. Alex Azar, Secretary of the Dept. of Health and Human Services - Bipartisan Committee Leaders Request Information on COVID-19's Impact on Addiction & Overdose Crisis
06/09/2020 Keeping up the Fight Against the Opioid Crisis
02/06/2020 Greg Walden Statement on President Trump Signing Bill into Law to Combat Illicit Fentanyl Use
02/06/2020 Greg Walden Raises Concerns about Youth Vaping Epidemic
02/05/2020 The Oregonian - Op Ed by Greg Walden: Looking beyond the opioid epidemic
02/03/2020 Greg Walden Discusses Investigation into Opioid Manufacturers
01/29/2020 Greg Walden Statement on House Passage of Bill to Combat Illicit Fentanyl Use
01/29/2020 Collins, Walden Applaud Extension of Fentanyl Analogues Ban
01/28/2020 Providing for Consideration of H.R. Student Borrower Credit Improvement Act, and Providing for Consideration of Senate Amendment to H.R. Merchant Mariners of World War II Congressional Gold Medal Act of 2019
01/27/2020 Calling on House of Representatives to Act and Keep Dangerous Drugs off the Streets
01/23/2020 Letter to Gene Dodaro, Comptroller General of the Government Accountability Office - Republicans Request GAO to Review Grant Funding to Combat Opioid Crisis
01/15/2020 Hearing of the Subcommittee on Health of the House Energy and Commerce Committee - Walden Remarks at Hearing on Cannabis Policies
01/14/2020 Lawmakers Raise Concerns Over Increased Use of Cocaine and Methamphetamine
01/14/2020 Hearing of the Subcommittee on Oversight and Investigations of the House Energy and Commerce Committee - Walden Remarks at Oversight Hearing on Opioid Crisis
01/13/2020 Letter to Saeed Motahari, President and CEO of Insys Therapeutics, Inc. - Griffith, Energy and Commerce Republicans Press for Answers From Opioid Manufacturers
01/13/2020 Letter to Mark Trudeau, President and CEO of Mallinckrodt Pharmaceuticals - Griffith, Energy and Commerce Republicans Press for Answers From Opioid Manufacturers
01/13/2020 Letter to Craig Landau, President and CEO of Pureau Pharma L.P. - Griffith, Energy and Commerce Republicans Press for Answers From Opioid Manufacturers
10/31/2019 Walden Statement on Legislation to Fight Fentanyl
Page 1 of 8
arrow_upward